Advertisement
CHE vs UHS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHE is a Hold and UHS is a Hold.
CHE's RSI Oscillator ascending out of oversold territory
The RSI Oscillator for CHE moved out of oversold territory on September 25, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In 14 of the 22 cases the stock moved higher. This puts the odds of a move higher at 64%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 30 of 59 cases where CHE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 51%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on CHE as a result. In 45 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 49%.
The Moving Average Convergence Divergence (MACD) for CHE just turned positive on October 14, 2026. Looking at past instances where CHE's MACD turned positive, the stock continued to rise in 29 of 53 cases over the following month. The odds of a continued upward trend are 55%.
Following a +2.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHE advanced for three days, in 162 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.
Bearish Trend Analysis
CHE moved below its 50-day moving average on September 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CHE crossed bearishly below the 50-day moving average on September 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.
The Aroon Indicator for CHE entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.091) is normal, around the industry mean (208.195). P/E Ratio (25.870) is within average values for comparable stocks, (175.456). Projected Growth (PEG Ratio) (1.876) is also within normal values, averaging (2.498). Dividend Yield (0.005) settles around the average of (0.005) among similar stocks. P/S Ratio (2.714) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 36 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. CHE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 87 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
UHS's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for UHS turned positive on October 14, 2026. Looking at past instances where UHS's MACD turned positive, the stock continued to rise in 33 of 43 cases over the following month. The odds of a continued upward trend are 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on UHS as a result. In 63 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
Following a +4.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where UHS advanced for three days, in 236 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
The Aroon Indicator entered an Uptrend today. In 189 of 295 cases where UHS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UHS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
UHS broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.392) is normal, around the industry mean (208.195). P/E Ratio (7.244) is within average values for comparable stocks, (175.456). Projected Growth (PEG Ratio) (1.197) is also within normal values, averaging (2.498). Dividend Yield (0.004) settles around the average of (0.005) among similar stocks. P/S Ratio (0.621) is also within normal values, averaging (2.688).
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. UHS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UHS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
CHE | UHS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 18 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 12 Undervalued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 87 | 70 | |
SMR RATING 1..100 | 36 | 45 | |
PRICE GROWTH RATING 1..100 | 42 | 42 | |
P/E GROWTH RATING 1..100 | 30 | 80 | |
SEASONALITY SCORE 1..100 | 85 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
UHS's Valuation (11) in the Hospital Or Nursing Management industry is in the same range as CHE (12) in the Medical Or Nursing Services industry. This means that UHS’s stock grew similarly to CHE’s over the last 12 months.
UHS's Profit vs Risk Rating (70) in the Hospital Or Nursing Management industry is in the same range as CHE (87) in the Medical Or Nursing Services industry. This means that UHS’s stock grew similarly to CHE’s over the last 12 months.
CHE's SMR Rating (36) in the Medical Or Nursing Services industry is in the same range as UHS (45) in the Hospital Or Nursing Management industry. This means that CHE’s stock grew similarly to UHS’s over the last 12 months.
CHE's Price Growth Rating (42) in the Medical Or Nursing Services industry is in the same range as UHS (42) in the Hospital Or Nursing Management industry. This means that CHE’s stock grew similarly to UHS’s over the last 12 months.
CHE's P/E Growth Rating (30) in the Medical Or Nursing Services industry is somewhat better than the same rating for UHS (80) in the Hospital Or Nursing Management industry. This means that CHE’s stock grew somewhat faster than UHS’s over the last 12 months.
| CHE | UHS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 64% | 2 days ago 34% |
| Stochastic ODDS (%) | 2 days ago 51% | 2 days ago 56% |
| Momentum ODDS (%) | 2 days ago 49% | 2 days ago 67% |
| MACD ODDS (%) | 2 days ago 55% | 2 days ago 77% |
| TrendWeek ODDS (%) | 2 days ago 52% | 2 days ago 68% |
| TrendMonth ODDS (%) | 2 days ago 53% | 2 days ago 69% |
| Advances ODDS (%) | 2 days ago 50% | 2 days ago 72% |
| Declines ODDS (%) | 9 days ago 49% | 17 days ago 67% |
| BollingerBands ODDS (%) | N/A | 2 days ago 54% |
| Aroon ODDS (%) | 2 days ago 33% | 2 days ago 64% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CHE’s FA Score shows that 2 FA rating(s) are green while UHS’s FA Score has 1 green FA rating(s).
- CHE’s FA Score: 2 green, 3 red.
- UHS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CHE’s TA Score shows that 5 TA indicator(s) are bullish while UHS’s TA Score has 4 bullish TA indicator(s).
- CHE’s TA Score: 5 bullish, 4 bearish.
- UHS’s TA Score: 4 bullish, 4 bearish.
Price Growth
CHE (@Hospital/Nursing Management) experienced а +3.45% price change this week, while UHS (@Hospital/Nursing Management) price change was +6.62% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.81%. For the same industry, the average monthly price growth was -7.16%, and the average quarterly price growth was +16.84%.
Reported Earning Dates
CHE is expected to report earnings on Oct 27, 2026.
UHS is expected to report earnings on Oct 27, 2026.
Industries' Descriptions
@Hospital/Nursing Management (-0.81% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XMLV | 64.27 | 0.41 | +0.64% |
| Invesco S&P MidCap Low Volatility ETF (XMLV) | |||
| PBUS | 77.34 | 0.20 | +0.26% |
| Invesco MSCI USA ETF (PBUS) | |||
| XMAG | 25.79 | N/A | N/A |
| Defiance Large Cap ex-Mag 7 ETF | |||
| DLMY | 30.87 | N/A | N/A |
| FT Vest U.S. Equity Dual Directional Buffer ETF - May (DLMY) | |||
| QLDY | 39.54 | -0.07 | -0.19% |
| Defiance Nasdaq 100 LightningSpread Income ETF (QLDY) | |||
CHE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CHE has been loosely correlated with UHS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CHE jumps, then UHS could also see price increases.
| Ticker / NAME | Correlation To CHE | 1D Price Change % | ||
|---|---|---|---|---|
| CHE | 100% | +0.44% | ||
| UHS - CHE | 44% Loosely correlated | +0.79% | ||
| PNTG - CHE | 33% Poorly correlated | +3.55% | ||
| ENSG - CHE | 32% Poorly correlated | +1.29% | ||
| OPCH - CHE | 32% Poorly correlated | +0.32% | ||
| NHC - CHE | 23% Poorly correlated | +4.71% | ||
More | ||||
UHS and
Correlation & Price change
A.I.dvisor indicates that over the last year, UHS has been loosely correlated with HCA. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if UHS jumps, then HCA could also see price increases.